Discuss drug abuse and the opioid epidemic F. Describe the principles of addiction treatment. Describe current regulatory issues related to opioid prescribing 2/28/17: Exam Two 3/2/17: Cardiology One Hypertension Lehne: Chapters 41, 42, 43, 44, 45, 46, 47 Porth: Chapters 29, 31 Learning Objectives Describe the prevalence and pathophysiology related to hypertension Describe the use of non-drug measures in the treatment of hypertension Discuss the following mechanism of action, side effects, patient education related to a. Diuretics Renin-Angiotension-Aldosterone medications (RAAS) Calcium Channel Blockers Vasodilators Beta Blockers 3/14/17: Cardiology 2 Hyperlipidemia & Heart Failure Lehne: Chapters 48 & 50 Porth: Chapters 32 & 34 Learning Objectives Describe the prevalence and pathophysiology related to hyperlipidemia & metabolic syndrome Identify the use of non-drug measures in the treatment of hyperlipidemia Describe the use of medications in the treatment of hyperlipidemia HMG-CoA Reductase Inhibitors (Statins) Niacin Bile Acid Sequestrants
Discuss drug abuse and the opioid epidemic F. Describe the principles of addiction treatment. Describe current regulatory issues related to opioid prescribing 2/28/17: Exam Two 3/2/17: Cardiology One Hypertension Lehne: Chapters 41, 42, 43, 44, 45, 46, 47 Porth: Chapters 29, 31 Learning Objectives Describe the prevalence and pathophysiology related to hypertension Describe the use of non-drug measures in the treatment of hypertension Discuss the following mechanism of action, side effects, patient education related to a. Diuretics Renin-Angiotension-Aldosterone medications (RAAS) Calcium Channel Blockers Vasodilators Beta Blockers 3/14/17: Cardiology 2 Hyperlipidemia & Heart Failure Lehne: Chapters 48 & 50 Porth: Chapters 32 & 34 Learning Objectives Describe the prevalence and pathophysiology related to hyperlipidemia & metabolic syndrome Identify the use of non-drug measures in the treatment of hyperlipidemia Describe the use of medications in the treatment of hyperlipidemia HMG-CoA Reductase Inhibitors (Statins) Niacin Bile Acid Sequestrants
nurs-331_pharmacology_syllabus.docx